Bpifrance

Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Transverse Venture Capital Investments Division

Benoit Barteau Ph.D

Investment Director

Nicolas Berdou

Investment Director, Defense Expert

Clarisse Blandin

Investment Director

Elyssa Maufras du Châtellier

Investment Director

Edouard Combette

Investment Director

Charlotte Corbaz

Investment Drector - Large Venture

Nicolas Dardenne

Senior Investment Director, Normandy (Caen Rouen)

Arnaud Despoisse

Director of Occitanie Participations

Philippe Dutheil

Investment Director

Mailys Ferrere

Director of Large Venture Investments

Romain Fourcade

Investment Director

Paul-Francois Fournier

Executive Director, Innovation Department

Pierre Gillet

Investment Director

Vanessa Giraud

Director of Environmental Impact Funds

Alessandro Gonella

Director

Gwenael Hamon

Investment Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Louis Janneau

Investment Director and Fund Manager

Magali Joessel

Director of Funds

So-Yeon Koo

Senior Investment Manager

Jérôme Langlade

Investment Director Aquitaine / Limousin / Poitou-Charentes

Eric Lefebvre

Director

Stephane Lefevre-Sauli

Senior Investment Director

Arnaud Legardeur

Investment Director

Chahra Louafi

Senior Investment Director

Serge Mesguich

Director of FIT

Laure Michel

Investment Director

Louis Molis

Investment Director

Jean-Francois Morin

Investment Director

Sébastien Moynot

Director

Adrien Muller

Investment Director

Adrien Néel

Investment Director

Axel Piriou

Director of Investments

Olivier Rameil

Senior Investment Director / VC seed

Vincent Roque

Director

Thibaut Roulon Ph.D

Investment Director

Gilles Schang

Deputy Managing Director

Bruno Villeneuve

Associate

Jean-Marie Fougeray

Senior Investment Director, Brittany

Past deals in Paris

GenSight Biologics

Post in 2025
GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

Histovery

Venture Round in 2025
Histovery SAS is a Paris-based company that specializes in developing software and augmented reality solutions for cultural sites and museums. Founded in 2006, Histovery offers an innovative product called HistoPad, a digital tablet designed to enhance the visitor experience by providing interactive, personalized, and engaging tours. This technology facilitates the exploration of cultural heritage through scientific reconstructions, enabling users to rediscover historical sites in an immersive manner. One notable application of HistoPad technology is its use in the Château de Falaise, where it allows visitors to explore fully reconstructed rooms. Histovery aims to promote and enrich the experience of cultural visits, making heritage more accessible and appealing to the public.

Swan

Series B in 2025
Swan is a European fintech company that specializes in embedded finance, providing an online banking platform for businesses to create and manage their bank accounts. Founded in 2019 and based in Paris, Swan enables companies to integrate banking features, such as accounts, cards, and payments, into their own products through simple APIs. The platform processes over 200 million euros in transactions monthly for more than 60 companies across ten European countries. As a licensed financial institution and a principal member of Mastercard, Swan is regulated by the ACPR. The company was co-founded with the startup studio eFounders and has received growth capital from prominent venture capital investors. Swan is led by a team of fintech experts with extensive industry experience.

Upfund

Seed Round in 2024
Upfund, established in 2022 and headquartered in Paris, France, is a real estate technology company specializing in commercial property data. It offers a digital platform that aggregates and qualifies data, providing comprehensive insights into the office, retail, and business premises markets. The platform enables users, including brokers, investors, and lenders, to access data on transactions, foot traffic, and tenants, facilitating market analysis, location selection, and informed decision-making.

Beyond Aero

Series A in 2024
Beyond Aero is focused on developing the first electric business aircraft powered by hydrogen propulsion, capable of transporting six passengers over distances of up to 800 nautical miles, significantly surpassing battery-powered alternatives. Established in December 2020, the company is innovating the design of a CS23 aircraft to integrate hydrogen-electric propulsion, emphasizing fuel cell technology, hydrogen tank systems, and advanced cooling mechanisms. With headquarters in Toulouse, Paris, and Los Angeles, Beyond Aero has assembled a team of over 50 skilled engineers from prominent aerospace firms and is actively seeking to expand its workforce. The company has successfully raised over $44 million from various investors and has received $914 million in Letters of Intent for the production of 108 aircraft. Beyond Aero recently achieved a milestone with France's first manned, fully hydrogen-electric flight and is a participant in the World Economic Forum's First Movers Coalition, reflecting its dedication to advancing zero-emission aviation solutions.

OSS Ventures

Series B in 2024
OSS Ventures is a startup studio established in 2018 by Renan Devillières, dedicated to fostering innovation within the French industry through technological, environmental, social, and societal transitions. Since its inception, OSS Ventures has launched 15 startups primarily in France and internationally, while also investing in an additional four startups. The company focuses on sectors such as manufacturing and technology, with an emphasis on coding, the sharing economy, open-source solutions, smart sensors, big data, robotics, additive manufacturing, and blockchain. Through its initiatives, OSS Ventures aims to drive significant advancements and improvements in various industries.

C12 Quantum Electronics

Venture Round in 2024
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

Metyos

Pre Seed Round in 2024
Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing individual data, such as fat levels and energy metabolism dynamics, Metyos provides users with personalized fitness and nutrition plans. Their aim is to help individuals understand how their bodies respond to various actions, enabling them to make informed choices and effectively work towards their weight goals. Through this innovative approach, Metyos empowers users to regain control over their health and wellness.

Sequans Communications

Grant in 2024
Sequans Communications S.A. is a designer and supplier of cellular semiconductor solutions, specializing in 4G and 5G chips and modules tailored for massive, broadband, and critical Internet of Things (IoT) markets. Established in 2003 and headquartered in Paris, France, the company offers a diverse product portfolio that includes its Monarch LTE-M/NB-IoT and Calliope Cat 1 chip platforms for 5G/4G massive IoT applications, known for their low power consumption and integrated functionalities. For broadband and critical IoT applications, Sequans provides the Cassiopeia Cat 4/Cat 6 4G and high-end Taurus 5G chip platforms, which are optimized for various sectors including residential, enterprise, and industrial uses. The company serves a global market with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

Scalinx

Series B in 2024
Scalinx is a fabless semiconductor company that specializes in the design and supply of Signal Conversion ASICs and ASSPs for various markets, including Test & Measurement, MilAero, and Communications. The company operates from its headquarters in Paris, with additional design sites in Caen and Grenoble. In Caen, a team of 20 employees industrializes the designs before production is outsourced to a network of subcontractors. Scalinx focuses on developing semiconductor technology that enables wideband and low-power signal conversion, facilitating applications in wired and wireless communications, test and measurement equipment, and radar. This approach allows clients to reduce costs and shorten development time for signal conversion technologies.

EYEGAUGE

Grant in 2023
eyeGauge is a Paris-based deep tech start-up dedicated to transforming the maritime industry by facilitating the decarbonization of maritime transportation. The company aims to help shipping companies meet International Maritime Organization targets by reducing greenhouse gas emissions by at least 50% by 2050. To comply with decarbonization regulations, ship owners must accurately measure and report emissions after every voyage. However, 85% of the world's fleet currently relies on manual data collection, which is often unreliable and difficult to analyze. eyeGauge addresses this challenge by offering an innovative, automated solution that collects data from onboard systems in a contactless and non-invasive manner. This technology generates consistent and comparable data, creating a digital model of a vessel's equipment and machinery. By providing insights into operations, eyeGauge enables shipping companies to identify optimization opportunities and enhance efficiency, ultimately supporting their efforts to reduce emissions and comply with regulations.

Eligo Bioscience

Series B in 2023
Eligo Bioscience S.A.S is a biotechnology company based in Paris, France, that specializes in the development of Eligobiotics, a new class of antimicrobials designed to target specific bacteria based on their genetic makeup. Founded in 2014, the company utilizes a combination of CRISPR/Cas technology and engineered phage capsids to create antibiotics capable of addressing microbiome-related diseases and combating resistant pathogens. These programmed antimicrobials aim to eradicate virulent bacteria within the human microbiome, facilitating the creation of advanced therapeutics for conditions caused by superbugs. Eligo Bioscience's innovative approach positions it at the forefront of microbiome precision therapies and next-generation antibiotic solutions.

Adionics

Series B in 2023
Adionics is a technology provider based in Paris, France, specializing in saline water treatment and desalination supply chains. Founded in 2012, the company focuses on developing innovative technologies for the selective extraction of salts from brine, seawater, and other salty waters. Its AquaOmnes technology effectively removes salt from water, while Flionex is an ion-absorbing liquid technology designed to bind salts, including lithium. Adionics serves various industries, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes and enable lithium recycling from batteries, aiming to provide efficient and environmentally friendly solutions for extracting valuable minerals.

GenSight Biologics

Post in 2023
GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

Albert

Venture Round in 2023
Albert is a software company that provides a SaaS platform. The company was founded in 2018 and is based in Paris, France.

Umiami

Series A in 2023
Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

Circul'Egg

Grant in 2023
Circul'Egg specializes in recycling eggshells from various companies, converting them into two primary products: calcium carbonate powder and shell membrane powder. By promoting sustainable practices within the circular economy, Circul'Egg addresses the growing demand for eco-friendly ingredients in the animal feed, nutraceutical, and cosmetics markets. Its offerings are designed to meet the needs of various stakeholders, including those in pet food, farm animal feed, dietary supplements, and cosmetic industries. The company emphasizes the natural, biobased, and vegetarian aspects of its products, ensuring they are both environmentally friendly and rich in valuable minerals and biomolecules. Established in Paris, Ile-de-France, France, Circul'Egg plays a crucial role in transforming waste into valuable resources for multiple sectors.

Remixt

Grant in 2023
Remixt is a leading Diversity, Equity and Inclusion tech platform dedicated to preventing key HR risks caused by harassment and discrimination. The company is headquartered in Paris, France, with employees in Paris, San Francisco, Toulouse and Annecy. Remixt’s clients include global corporations Heineken, Société Générale, Accenture, Groupe BPCE-Natixis and Hexagon. For more information: http://www.remixt.co

Resolve Stroke

Seed Round in 2023
Resolve Stroke, headquartered in Paris, is a HealthTech company dedicated to revolutionizing medical imaging. It specializes in enhancing ultrasound technology to extract more detailed information, enabling advanced diagnostics, particularly in neurology. The company's innovative software engines improve ultrasound contrast, resolution, and penetration depth, allowing for the visualization of micro-vessels through the human skull in 3D. With a global focus, Resolve Stroke aims to accelerate treatments for over 1 billion people affected by brain diseases. To date, it has secured €3 million in pre-seed funding to pioneer software-based ultrasound innovation.

Swan

Series B in 2023
Swan is a European fintech company that specializes in embedded finance, providing an online banking platform for businesses to create and manage their bank accounts. Founded in 2019 and based in Paris, Swan enables companies to integrate banking features, such as accounts, cards, and payments, into their own products through simple APIs. The platform processes over 200 million euros in transactions monthly for more than 60 companies across ten European countries. As a licensed financial institution and a principal member of Mastercard, Swan is regulated by the ACPR. The company was co-founded with the startup studio eFounders and has received growth capital from prominent venture capital investors. Swan is led by a team of fintech experts with extensive industry experience.

Matera

Series B in 2023
Matera, a Paris-based company incorporated in 2017, operates an online condominium management platform aimed at simplifying the lives of co-owners. The platform enables residents to effectively manage their buildings by handling administrative and accounting tasks, generating necessary documents and bills tailored to each co-owner's needs. By providing a secure online environment for these functions, Matera allows co-owners to take control of their property management without relying on traditional professional syndicates. Additionally, the platform offers legal and accounting support, further streamlining the management process for building co-owners.

Santexpat.fr

Series A in 2023
Santexpat is a health insurance platform tailored for French expatriates, operating in over 200 countries. Established in 2020 and headquartered in Paris, it provides users with the ability to analyze more than 100 health insurance options and subscribe directly online. The platform displays insurer prices aligned with public rates, ensuring transparency by including all costs without additional fees. Users can manage their insurance premiums directly through the site of their chosen insurer. Additionally, Santexpat offers 24/7 teleconsultations with French-speaking doctors, enhancing access to healthcare for expatriates.

Pricemoov

Series A in 2023
Pricemoov, established in 2016 and headquartered in Paris, France, specializes in price management and optimization. It offers an online platform that leverages data science and automation to analyze sales history and current demand, enabling businesses to set optimal prices for their products or services. The platform caters to both B2B and B2C companies, helping them adapt to market dynamics, empower sales teams, and ultimately unlock revenue potential.

Pili

Series A in 2023
PILI Inc. is a company based in Paris, France, that specializes in researching and manufacturing bio-fabricated colors derived from microorganisms. Founded in 2012, the company focuses on designing enzymes and fermentation biotechnologies that convert sugar into sustainable and long-lasting dyes and pigments. PILI produces renewable inks as an eco-friendly alternative to traditional toxic and non-recyclable options. The company emerged from a collaboration among a biologist, a designer, and a financial analyst in a biohacker space, leading to the creation of innovative products like a pen fed by bacteria. By utilizing microorganisms, PILI aims to replace petrochemical and non-sustainable vegetable dyes, promoting sustainable development while also helping businesses reduce costs.

Ganymed Robotics

Debt Financing in 2023
Ganymed Robotics SAS is a medical device company based in Paris, France, established in 2018. The company specializes in developing advanced robotics technologies and software aimed at enhancing surgical precision in orthopedic procedures, particularly focusing on knee replacement surgeries. Its innovative therapeutic device is designed to improve patient outcomes and streamline the surgical process, enabling orthopedic surgeons to reduce operating times and enhance their overall experience. By integrating robotics into surgical practices, Ganymed Robotics aims to advance the efficiency of care delivery in the orthopedic field.

Hummink

Seed Round in 2022
Hummink is a Paris-based company founded in 2020 that specializes in additive manufacturing technology focused on nanoscale design and production. The company utilizes a patented technology that integrates a nanometric pen with an oscillating microresonator to achieve capillary deposition of various liquids. This innovative approach allows clients in the semiconductor and molecular diagnostic industries to create large objects while maintaining high resolution and precision on substrates ranging from millimetric to centimetric scales. Hummink's advancements in nano-printing technology position it as a valuable player in the field of precision manufacturing.

Jeudimerci

Series A in 2022
JeudiMerci is a marketing platform headquartered in Paris, France, that simplifies the process of sending physical gifts, comparable to sending an email. Founded in 2019, the company focuses on enhancing B2B customer experiences by automating the delivery of gifts at crucial points in the customer journey. Its services include both online and offline marketing solutions, which facilitate centralized gifting outreach to engage customers and employees effectively. By leveraging this platform, businesses can create meaningful connections with prospects and clients, ultimately driving brand engagement and development.

Supercosi

Seed Round in 2022
Supercosi is a mobile game start-up based in Paris, founded in 2021 by Charlotte Lavergne and Jean-Baptiste Fleury. The company specializes in developing and launching casual games designed for a wide audience, emphasizing both accessibility and engagement. Supercosi aims to enhance the gaming experience by incorporating competitive and collaborative elements, allowing players to enjoy relaxed gameplay while participating in enjoyable challenges. By blending creativity, data, and technology, the studio strives to create immersive gaming experiences that appeal to all types of players.

Outsight

Series B in 2022
Outsight SA, founded in 2019 and based in Paris, France, specializes in developing 3D Semantic Camera technology that enables simultaneous perception and understanding of environments in three dimensions. This technology detects the material composition of objects and is applicable in commercial and off-road vehicles, as well as in monitoring large areas in real-time. The company's Spatial AI solutions utilize 3D LiDAR data to track and digitize the movements of people and vehicles. They provide transportation hubs, such as airports and train stations, along with sports venues and industrial sites, with accurate and anonymous spatial intelligence data. This information aids in enhancing operational efficiency, improving visitor experiences, and bolstering safety and security measures.

Homa Games

Series B in 2022
Homa Games is a gaming technology platform based in Paris, France, that focuses on creating and publishing mobile games, particularly in the hyper-casual and idle genres. The company collaborates with over 200 carefully selected studios globally to develop games, having published more than 30 titles, including NERF Epic Pranks!, Sky Roller, and Idle World. Homa Games provides game creators with data-driven tools and human expertise, enabling them to transform their creative concepts into commercially successful games. The company also specializes in user acquisition, monetization, and offers automation and optimization services for app production and publishing, aimed at enhancing the gaming experience and supporting mobile game developers in growing their applications from inception.

Devialet

Venture Round in 2022
Devialet is an audio technology company based in Paris, founded in 2007, that specializes in developing advanced acoustic engineering solutions. The firm offers a range of audio equipment, including connected speakers and wireless earbuds, such as its Gemini model. By integrating digital and analog technologies, Devialet aims to enhance the audio experience for consumers. The company's mission is to make its innovative audio technology universally accessible, contributing to the advancement of sound amplification and overall musical enjoyment through its sophisticated production processes.

Pytheas Capital Advisors

Venture Round in 2022
Pytheas Capital Advisors is a Paris-based financial advisory firm established in 2014, specializing in alternative funding solutions for suppliers, buyers, and institutional investors. The company focuses on providing innovative financing options backed by real economic assets, including trade receivables. Its services encompass supplier payment solutions, payment factories, reverse factoring, and supply chain financing. Through its platform, Pytheas Capital Advisors enables principals and suppliers to effectively monitor billing statuses and manage invoice assignments without recourse, thereby enhancing financial efficiency and liquidity for its clients.

DeepLife

Series A in 2022
DeepLife is a biotech company based in Paris, France, founded in 2019. It focuses on developing digital twins of cells to enhance drug discovery processes. By utilizing deep learning techniques on multi-omics data, DeepLife models cellular behavior and simulates responses to various genetic screenings, such as siRNA and CRISPR-Cas9. This approach allows the identification of new drug targets, biomarkers, and potential drug candidates, enabling a better understanding of drug resistance and sensitivity. The company's mission is to advance systems biology and facilitate the transition of laboratory discoveries to clinical applications. DeepLife collaborates with academic institutions to leverage expertise and drive innovation in the biopharmaceutical industry, ultimately aiming to match the right drug to the right patient.

Siteflow

Series A in 2022
Siteflow is a developer of cloud-based service management software tailored for complex industries such as nuclear, manufacturing, special works, and oil and gas. Founded in 2017 and headquartered in Paris, France, the company offers Siteflow Builder, an application designed to streamline operations by aiding in the preparation, execution, and monitoring of projects on-site. This software facilitates real-time progress tracking, enhances collaboration among team members, and standardizes business operations. By focusing on user-friendly interfaces and functionalities that add direct value, Siteflow addresses the unique challenges faced by regulated industries, where traditional tools have often fallen short. The company also supports organizations in their digital transformation efforts, ensuring a smooth transition towards operational excellence by redesigning workflows and improving day-to-day activities for engineers, project managers, and operators.

Strapi

Series B in 2022
Strapi is an open-source software company based in Paris, founded in 2016. It specializes in providing a headless content management system (CMS) that enables developers to efficiently build, deploy, and manage application backends with minimal effort. By decoupling the frontend from the CMS, Strapi allows developers to utilize their preferred front-end tools and frameworks while offering a robust API for content delivery across various devices. The platform features a powerful dashboard and tools for API prototyping and management, streamlining the content distribution process for editors. This flexibility and user-friendly approach position Strapi as a valuable resource for developers seeking to create dynamic and scalable applications.

DCbrain

Venture Round in 2022
DCbrain, established in 2014 and based in Paris, France, is a deep-tech Software as a Service (SaaS) company. It specializes in providing an optimization platform that employs AI and Hybrid AI algorithms, primarily serving the energy and supply chain sectors. The company's platform offers a visualization interface and predictive analysis tools to help clients identify network anomalies, prevent incidents, and forecast future network evolution, even in complex network configurations.

Arianee

Series A in 2022
Arianee SA, founded in 2018 and based in Paris, France, specializes in digital certifications for products using a blockchain platform compatible with Ethereum. The company aims to enhance the authentication of branded products through a universal open-source protocol that creates an immutable ledger documenting all aspects of product creation and sales. This technology facilitates secure and transparent interactions among brands, product owners, and third-party retailers, establishing a global standard for the digital certification of valuable items. Arianee's mission extends to enriching the relationship between brands and consumers by enabling direct and ongoing engagement through digital assets, such as NFTs.

Umiami

Series A in 2022
Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

Umiami

Series A in 2022
Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

Kayrros

Venture Round in 2022
Kayrros is a leading advanced data analytics company that specializes in providing actionable insights for the global energy market. With a team of over 100 employees from more than 15 nationalities, Kayrros operates from its headquarters in Paris and has additional offices in Houston, London, New York, and Singapore. The company integrates alternative and market data to create unique product offerings that enhance decision-making across the energy sector. Its platform focuses on environmental intelligence and asset observation, delivering critical insights related to greenhouse gas reduction, ecosystem protection, and energy transition management. Kayrros aims to support governments, companies, and investment markets in assessing the climate impact of energy and industrial activities, thereby enabling faster and more informed decisions. The company’s solutions are designed to be scalable and continuously expand to include new geographic regions and data sources, enhancing transparency in energy markets worldwide.

Doctolib

Series F in 2022
Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.

Specify

Seed Round in 2022
Specify is a design data platform founded in Paris in 2018 by a team of former designers, product managers, and developers. The company assists organizations in managing their brand identity by automatically collecting, storing, and distributing design tokens and assets. This capability enables clients to maintain brand consistency across various products and platforms. After successfully onboarding over 1,000 international teams and two years of bootstrapping, Specify secured a pre-seed investment of $1 million. The company has positioned itself as a leader in the DesignOps and Design Systems sectors, being the first to offer a dedicated Design Data Platform. Additionally, Specify is an active member of the Design Tokens Community Group, which aims to establish standards for sharing design elements across tools and products at scale.

Silvr

Series A in 2022
Silvr is a Paris-based company that transforms the funding landscape for entrepreneurs, particularly in the e-commerce sector. By utilizing digital business data to forecast future revenues, Silvr offers quick, equity-free financing solutions to e-merchants who typically face challenges in securing traditional bank loans. Its platform allows these businesses to access funding in as little as 24 hours, enabling them to invest in growth and marketing initiatives while repaying the funding based on their sales performance. Silvr aims to make financing more accessible and scalable for European entrepreneurs, deploying millions of euros each month to support their growth.

Diaccurate

Grant in 2022
Diaccurate is a biotechnology company based in Paris, France, that focuses on researching and developing treatments for various diseases, including HIV infection and several types of cancer. Founded in 2012, the company targets conditions such as endocrine-resistant metastatic breast tumors, glioblastoma, and refractory acute myeloid leukemia. Diaccurate is dedicated to exploring innovative therapeutic approaches in oncology, aiming to provide effective solutions for patients facing these challenging and often incurable diseases.

Ubble.ai

Convertible Note in 2021
Ubble.ai is a Paris-based company founded in 2018 that specializes in online identity verification through its software as a service platform. The company utilizes a combination of video live streaming, computer vision, and artificial intelligence to provide a seamless and secure identity verification process. Ubble's technology helps businesses combat fraud by enabling them to validate consumers' identities efficiently and in a manner that respects privacy. Through its innovative approach, Ubble aims to simplify the identity verification experience while enhancing security for users and businesses alike.

Egle Therapeutics

Series A in 2021
Egle Therapeutics SAS is a biotechnology company based in Paris, France, founded in 2020. It specializes in developing innovative immunotherapies that target immune suppressor regulatory T-cells (Tregs) for the treatment of oncology and autoimmune diseases. The company's research focuses on a proprietary drug pipeline that includes computationally designed IL-2 variants aimed at modulating Treg activity. This approach seeks to either engage or dis-engage Tregs, facilitating the development of therapies that can effectively combat cancer and other related conditions by addressing the immune suppression caused by Tregs. Egle Therapeutics aims to advance its unique portfolio to provide new treatment options in the healthcare field.

Swile

Series D in 2021
Swile is a Paris-based company founded in 2018 by Loïc Soubeyrand, focused on transforming employee engagement and benefits management. The company offers an all-in-one smartcard that consolidates various employee benefits, including meal vouchers, gift vouchers, and mobility benefits, thereby disrupting the traditional meal voucher market in France. In addition to these services, Swile provides a super app designed to enhance workplace culture through features such as employee recognition, event organization, collections, and peer-to-peer payments. The platform also includes tools for conducting employee engagement surveys and delivering insightful analytics, allowing businesses to streamline expense management and simplify the distribution of employee benefits. By enabling employees to access and manage their benefits electronically, Swile aims to improve overall financial well-being within organizations.

Swan

Series A in 2021
Swan is a European fintech company that specializes in embedded finance, providing an online banking platform for businesses to create and manage their bank accounts. Founded in 2019 and based in Paris, Swan enables companies to integrate banking features, such as accounts, cards, and payments, into their own products through simple APIs. The platform processes over 200 million euros in transactions monthly for more than 60 companies across ten European countries. As a licensed financial institution and a principal member of Mastercard, Swan is regulated by the ACPR. The company was co-founded with the startup studio eFounders and has received growth capital from prominent venture capital investors. Swan is led by a team of fintech experts with extensive industry experience.

Vestiaire Collective

Series I in 2021
Vestiaire Collective is a social commerce platform specializing in the buying and selling of luxury pre-owned fashion items. Founded in 2009 and headquartered in Paris, the company promotes sustainable fashion by encouraging the circular fashion movement, which aims to reduce overproduction and waste in the industry. Vestiaire Collective boasts a unique inventory of approximately 3 million items, with around 140,000 new listings added weekly, catering to a community of over 7.5 million fashion enthusiasts across 50 countries. The platform offers a curated selection of vintage and luxury clothing, jewelry, accessories, and footwear, enhancing the shopping experience through verified and desirable products. By fostering a highly engaged community, Vestiaire Collective empowers its members to actively participate in a more sustainable fashion economy.

Solstyce

Venture Round in 2021
Solstyce is a Paris-based provider of energy transition and environmental innovation solutions. The company offers a wide range of services, including photovoltaic systems, electric mobility solutions, insulation, waterproofing, and carbon performance initiatives. By focusing on the evolving needs of clients, Solstyce serves as a comprehensive resource for environmental innovation. With a team of experts dedicated to developing advanced solutions, the company aids clients in optimizing energy usage, minimizing their carbon footprint, and enhancing the sustainability of their operations. Whether through the installation of rooftop solar panels, insulation services, or electric vehicle charging solutions, Solstyce delivers tailored approaches to meet the specific requirements of each client.

Gourmey

Seed Round in 2021
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.

ManoMano

Series F in 2021
ManoMano is an online marketplace specializing in DIY, home improvement, and gardening products. Founded in 2013 and headquartered in Paris, France, the platform serves a community of DIY enthusiasts, providing not only a wide range of products but also expert advice and tips for various projects. Customers can connect with merchants to purchase items directly at competitive prices, enhancing their gardening and home improvement endeavors. ManoMano's data-driven approach enables efficient product offerings, making it a valuable resource for individuals looking to undertake DIY projects.

Umiami

Seed Round in 2021
Umiami is a French food-tech startup founded in 2020 and based in Paris, focused on developing plant-based food technology aimed at reducing meat consumption. The company specializes in creating plant-based whole-cuts that utilize plant proteins, providing consumers with alternatives that closely replicate the taste, texture, and aroma of traditional meat products. By offering these innovative solutions, Umiami seeks to address the growing demand for sustainable food options while promoting healthier dietary choices.

WeMaintain

Series B in 2021
WeMaintain, established in 2017, is a technology-driven company specializing in elevator maintenance. Headquartered in Paris, London, and Singapore, it combines the expertise of lift engineers with proprietary technology to optimize and streamline maintenance services for building managers. The company's platform provides real-time data and insights, reducing costs, energy consumption, and equipment downtime, while enhancing overall performance.

C12 Quantum Electronics

Grant in 2021
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

C12 Quantum Electronics

Seed Round in 2021
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.

Adionics

Seed Round in 2021
Adionics is a technology provider based in Paris, France, specializing in saline water treatment and desalination supply chains. Founded in 2012, the company focuses on developing innovative technologies for the selective extraction of salts from brine, seawater, and other salty waters. Its AquaOmnes technology effectively removes salt from water, while Flionex is an ion-absorbing liquid technology designed to bind salts, including lithium. Adionics serves various industries, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes and enable lithium recycling from batteries, aiming to provide efficient and environmentally friendly solutions for extracting valuable minerals.

Matera

Series B in 2021
Matera, a Paris-based company incorporated in 2017, operates an online condominium management platform aimed at simplifying the lives of co-owners. The platform enables residents to effectively manage their buildings by handling administrative and accounting tasks, generating necessary documents and bills tailored to each co-owner's needs. By providing a secure online environment for these functions, Matera allows co-owners to take control of their property management without relying on traditional professional syndicates. Additionally, the platform offers legal and accounting support, further streamlining the management process for building co-owners.

Sun'R

Venture Round in 2021
Sun'R is a Paris-based company focused on the development, construction, and operation of photovoltaic energy production plants. The company manages a portfolio of 10 MWp rooftop-mounted photovoltaic plants and employs a diverse team of engineers, mathematicians, and computer scientists. This team is dedicated to creating in-house operational and piloting capabilities, as well as optimization software and storage technologies tailored to meet specific environmental needs. Sun'R aims to contribute to sustainable energy solutions through its innovative approach to solar power generation.

Biophytis

Post in 2021
Biophytis SA is a clinical-stage biotechnology company based in Paris, France, dedicated to developing therapeutics that aim to slow degenerative processes linked to aging and enhance functional outcomes for patients with age-related diseases. The company focuses on activating key biological resilience pathways to mitigate the effects of various biological and environmental stresses that contribute to these conditions. Biophytis has two primary drug candidates: Sarconeos (BIO101), an orally administered small molecule being developed for neuromuscular diseases such as sarcopenia and Duchenne muscular dystrophy, and Macuneos (BIO201), also an orally administered small molecule targeting retinal diseases like dry age-related macular degeneration and Stargardt disease. The company has established a collaboration agreement with AFM-Telethon for the development of Sarconeos. Founded in 2006, Biophytis aims to become a leader in aging science by providing innovative therapies to address the needs of patients with limited treatment options.

Biophytis

Grant in 2021
Biophytis SA is a clinical-stage biotechnology company based in Paris, France, dedicated to developing therapeutics that aim to slow degenerative processes linked to aging and enhance functional outcomes for patients with age-related diseases. The company focuses on activating key biological resilience pathways to mitigate the effects of various biological and environmental stresses that contribute to these conditions. Biophytis has two primary drug candidates: Sarconeos (BIO101), an orally administered small molecule being developed for neuromuscular diseases such as sarcopenia and Duchenne muscular dystrophy, and Macuneos (BIO201), also an orally administered small molecule targeting retinal diseases like dry age-related macular degeneration and Stargardt disease. The company has established a collaboration agreement with AFM-Telethon for the development of Sarconeos. Founded in 2006, Biophytis aims to become a leader in aging science by providing innovative therapies to address the needs of patients with limited treatment options.

OpenClassrooms

Series C in 2021
OpenClassrooms is an online education platform based in Paris, France, founded in 2007. It has emerged as one of Europe’s largest education-to-employment platforms, serving 355,000 students across 140 countries. The company offers a variety of accredited online courses and degree programs, including Associate, Bachelor’s, and Master’s level diplomas. OpenClassrooms focuses on vocational training in high-demand fields such as coding, IT, product management, data management, marketing, communications, and UX design. Its educational model emphasizes competency-based learning, combining high-quality online coursework with personalized mentorship, project-based experiences, and career coaching. The platform also collaborates with numerous corporate partners, providing a job guarantee to enhance employability for its graduates.

Ornikar

Series C in 2021
Ornikar SAS is an online driving school based in Paris, France, established in 2014. The company specializes in providing an affordable and streamlined approach to obtaining a driving license, catering to the needs of current and future generations. Ornikar offers a platform where candidates can learn and practice traffic laws, supported by a network of state-qualified instructors who deliver mobile driving lessons at reduced prices. In addition to facilitating access to driving licenses, Ornikar also provides tailored options for first-time car buyers and young driver insurance, enhancing the overall learning experience and promoting automotive mobility.

Step Pharma

Series B in 2021
Step Pharma, established in 2014 and based in Paris, France, focuses on developing innovative small molecule therapeutics for immunosuppressive therapies aimed at treating autoimmune diseases. As a spin-off from the Imagine Institute, the company leverages research on genetic immunodeficiencies conducted by Pr. Alain Fischer. Step Pharma operates as a joint venture with contributions from Imagine, Sygnature Discovery, and Kurma Partners, combining expertise in drug discovery and funding within the healthcare and biotechnology sectors. The company's proprietary therapeutics utilize a novel class of oral nucleotide synthesis inhibitors that specifically target cytidine triphosphate synthase 1 (CTPS1). This targeted approach enables selective modulation of immune cell populations, such as T and B cells, leading to enhanced treatment efficacy and improved therapeutic outcomes for patients with autoimmune conditions.

OncoDiag

Grant in 2021
OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

Arianee

Seed Round in 2021
Arianee SA, founded in 2018 and based in Paris, France, specializes in digital certifications for products using a blockchain platform compatible with Ethereum. The company aims to enhance the authentication of branded products through a universal open-source protocol that creates an immutable ledger documenting all aspects of product creation and sales. This technology facilitates secure and transparent interactions among brands, product owners, and third-party retailers, establishing a global standard for the digital certification of valuable items. Arianee's mission extends to enriching the relationship between brands and consumers by enabling direct and ongoing engagement through digital assets, such as NFTs.

SESAMm

Series B in 2021
SESAMm is a fintech company focused on leveraging big data and artificial intelligence to enhance investment strategies. The firm specializes in analyzing vast amounts of web content through natural language processing and machine learning to generate analytics and investment signals. Its platforms, TextReveal and SignalReveal, provide comprehensive solutions for alpha research, catering to both fundamental and quantitative investment needs. With a team of 90 professionals located in cities such as Paris, New York, and Tokyo, SESAMm collaborates with prominent hedge funds, banks, and asset management firms globally. Additionally, the company emphasizes responsible and sustainable investing, offering insights that assist private equity firms, asset managers, and corporations in effectively managing their assets.

Aleia

Seed Round in 2021
Aleia is an IT firm based in Paris, France, founded in 2020. The company specializes in providing a platform that supports individuals and organizations in their artificial intelligence projects. Aleia's platform offers an open, secure, and industrialized solution that accelerates the development of AI applications. It enables users to extract, prepare, and process data, facilitating the design, optimization, and deployment of machine learning workflows from experimentation to production. By doing so, Aleia helps organizations enhance the performance of their AI initiatives and streamlines the transition from project conception to operational deployment.

Ekimetrics

Venture Round in 2020
Ekimetrics is a global consulting firm based in Paris, France, specializing in industrialized corporate data science solutions. The firm combines consulting expertise with advanced data science and technology to enhance company performance, growth, and profitability. Ekimetrics develops tailored solutions that deliver significant impact in under six months, focusing on areas such as data transformation, marketing performance, customer intelligence, pricing strategies, process optimization, and broader data solutions. Through its team of data scientists, the company emphasizes ethical and conscious practices in data and artificial intelligence, enabling clients to improve their marketing and operational performance while revitalizing their business models.

GrAI Matter Labs

Venture Round in 2020
GrAI Matter Labs, based in Paris with additional offices in Eindhoven and Silicon Valley, specializes in developing ultra-low power, programmable neuromorphic computing technology. The company focuses on creating brain-inspired chips that utilize spiking neural networks to enhance sensor analytics and machine learning capabilities, particularly for devices connected to the Internet of Things (IoT). These processors are designed to enable autonomous navigation for vehicles, robots, and drones, while also integrating intelligent AI into smart homes, smartphones, and wearable health monitoring devices. Founded in 2016, GrAI Matter Labs aims to optimize energy usage and improve efficiency in AI applications, providing solutions that allow machines to act and react in real time. The company seeks to redefine AI interactions, making them more intuitive and human-like.

Livestorm

Series B in 2020
Livestorm is a developer of a video communication tool that facilitates audience engagement through an intuitive browser-based platform. Founded in 2016 and headquartered in Paris, France, Livestorm enables teams to organize online events seamlessly from any device. The platform offers a comprehensive suite of tools, including the ability to create custom landing pages, send promotional emails and reminders, and host interactive online events featuring integrated chat, polls, and Q&A functionalities. Additionally, Livestorm provides advanced analytics to assess event performance, empowering businesses to effectively incorporate video communication into their strategies for attracting, engaging, and educating their audiences.

Braintale

Debt Financing in 2020
Braintale is a Paris-based company founded in 2018 that develops and distributes diagnostic and prognostic tools specifically designed for brain-injured patients. Its platform focuses on analyzing MRI reports to assist healthcare professionals in effectively diagnosing patients who are in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. With over 15 years of clinical development backing its products, Braintale aims to meet the expectations of both healthcare professionals and patients by providing accessible and effective tools for prognosis and diagnosis in critical care settings.

TISSIUM

Debt Financing in 2020
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Brevo

Series B in 2020
Brevo is a developer of a cloud-based digital marketing platform designed to assist businesses in enhancing customer engagement. Founded in 2012 and headquartered in Paris, France, the company provides an all-in-one suite that caters specifically to the marketing needs of small and medium-sized businesses, particularly in challenging markets. Brevo's platform covers the entire marketing process, from newsletter creation to analysis and reporting tools, as well as targeting modules. This enables businesses, e-commerce sellers, and agencies to foster customer relationships through comprehensive digital marketing campaigns, transactional messaging, and marketing automation, setting it apart from solutions aimed at enterprise-level clients.

Swan

Seed Round in 2020
Swan is a European fintech company that specializes in embedded finance, providing an online banking platform for businesses to create and manage their bank accounts. Founded in 2019 and based in Paris, Swan enables companies to integrate banking features, such as accounts, cards, and payments, into their own products through simple APIs. The platform processes over 200 million euros in transactions monthly for more than 60 companies across ten European countries. As a licensed financial institution and a principal member of Mastercard, Swan is regulated by the ACPR. The company was co-founded with the startup studio eFounders and has received growth capital from prominent venture capital investors. Swan is led by a team of fintech experts with extensive industry experience.

Medaviz

Series A in 2020
Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that facilitates immediate communication between patients and healthcare professionals. The service allows users to connect with various specialists, including general practitioners, pediatricians, gynecologists, and psychologists, at any time. By providing access to medical advice around the clock, Medaviz enables users to address their medical issues or emergencies efficiently, enhancing the convenience of healthcare access.

SideROS

Debt Financing in 2020
SideROS is a biotechnology company based in Paris, France, established in 2019. The company focuses on researching iron-targeting chemical compounds to develop drug candidates aimed at persister cancer cells, which are resistant to conventional treatments and linked to metastasis and relapse. One of its key developments is ironomycin, a chemical molecule that disrupts iron homeostasis in persister cancer cells, leading to cell death through a process known as ferroptosis. By targeting these resilient cancer cells, SideROS aims to advance cancer treatment options.

Comet Meetings

Series B in 2020
Comet Meetings is a Paris-based business specializing in modern meeting venues. It aims to enhance productivity, creativity, and well-being during corporate gatherings. Comet offers customizable spaces for meetings and business seminars, providing an alternative to traditional, often uninspiring locations. Their focus is on creating a positive customer experience, from the physical space to the overall meeting environment. Comet strives to make these high-quality meeting experiences accessible to a wide range of companies, offering competitive pricing.

Pixium Vision

Post in 2020
Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative retinal implant systems to restore vision for individuals who have lost sight due to degeneration of photoreceptor cells in the retina. Established in 2011, Pixium Vision's primary product is the PRIMA System, a bionic vision system designed to improve visual perception and promote greater independence among users. The company is advancing several devices, including the IRIS1, currently undergoing clinical trials, and the next-generation IRIS2, which aims to enhance visual acuity. Additionally, Pixium is working on the IRIS3, a sub-retinal implant that promises further improvements in vision. The company collaborates with prestigious institutions such as Stanford University, Moorfields Eye Hospital, and the Institut de la Vision, utilizing cutting-edge research in neural processing and micro-electronics to drive its innovations. Pixium Vision is supported by a consortium of prominent European venture capital firms.

Honing Biosciences

Pre Seed Round in 2020
Honing Biosciences SAS is a bio-therapeutics company based in Paris, France, specializing in the development and enhancement of cell-based therapies for cancer and other chronic diseases. The company utilizes its proprietary molecular CellTune technology to create tunable cell therapeutics that enable precise control over the dynamic delivery of proteins in patients. This innovation allows for the regulation of protein expression at the cell surface and the secretion of therapeutic agents such as enzymes, cytokines, and antibodies, which can be adapted based on the clinical progression of a patient's condition. Honing Biosciences also offers therapies like CAR-T cell therapy and checkpoint inhibitors, which aim to improve treatment efficacy while minimizing adverse effects associated with earlier therapeutic generations. Established in 2018, the company focuses on advancing immunotherapy and reconstituting cell therapies to better engage the body’s immune system in combating diseases.

Owkin

Series A in 2020
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Swile

Series C in 2020
Swile is a Paris-based company founded in 2018 by Loïc Soubeyrand, focused on transforming employee engagement and benefits management. The company offers an all-in-one smartcard that consolidates various employee benefits, including meal vouchers, gift vouchers, and mobility benefits, thereby disrupting the traditional meal voucher market in France. In addition to these services, Swile provides a super app designed to enhance workplace culture through features such as employee recognition, event organization, collections, and peer-to-peer payments. The platform also includes tools for conducting employee engagement surveys and delivering insightful analytics, allowing businesses to streamline expense management and simplify the distribution of employee benefits. By enabling employees to access and manage their benefits electronically, Swile aims to improve overall financial well-being within organizations.

Owkin

Series A in 2020
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

B-Hive Engineering

Venture Round in 2020
B-Hive Engineering is an engineering and operational consulting firm based in Mulhouse, France, with additional offices in Lyon and Paris, and operations in Montréal, Canada. Founded in 2017, the company specializes in providing technical assistance and project management services across various sectors, including chemistry, petrochemistry, energy, food, pharmaceuticals, biotechnology, automotive, rail, aeronautics, and civil engineering. B-Hive Engineering supports clients throughout the study and design phases of projects, offering operational support and training in project management to effectively address project challenges. The firm is dedicated to enhancing efficiency in industry, transport, and construction sectors.

Vestiaire Collective

Venture Round in 2020
Vestiaire Collective is a social commerce platform specializing in the buying and selling of luxury pre-owned fashion items. Founded in 2009 and headquartered in Paris, the company promotes sustainable fashion by encouraging the circular fashion movement, which aims to reduce overproduction and waste in the industry. Vestiaire Collective boasts a unique inventory of approximately 3 million items, with around 140,000 new listings added weekly, catering to a community of over 7.5 million fashion enthusiasts across 50 countries. The platform offers a curated selection of vintage and luxury clothing, jewelry, accessories, and footwear, enhancing the shopping experience through verified and desirable products. By fostering a highly engaged community, Vestiaire Collective empowers its members to actively participate in a more sustainable fashion economy.

TwicPics

Seed Round in 2020
TwicPics is a Paris-based company founded in 2018 that specializes in image and video processing software through its Application Program Interface (API). The company addresses the challenges posed by the increasing demand for visual content in marketing, which often leads to heavy website loads and longer page loading times. By automating the processing of images and videos, TwicPics enhances visual quality and web performance while reducing the carbon footprint of websites. Its platform provides real-time, device-adapted images tailored to various screen sizes and network conditions, improving user experience and site speed. This innovative solution is utilized by both major brands and startups to streamline workflows, boost key performance indicators such as conversion rates and engagement, and develop eco-friendly websites.

Extrality

Seed Round in 2020
Extrality is a company based in Paris, France, that specializes in developing a platform for rapid numerical simulations using machine learning. Founded in 2019, the platform is designed to simplify artificial intelligence-driven simulations, enabling engineers to quickly evaluate the aerodynamics, fluid dynamics, and thermal properties of products. By maintaining essential physical accuracy, Extrality's technology supports manufacturers in sectors such as aerospace, transportation, and energy, allowing them to significantly decrease their time-to-market for new products.

ManoMano

Series E in 2020
ManoMano is an online marketplace specializing in DIY, home improvement, and gardening products. Founded in 2013 and headquartered in Paris, France, the platform serves a community of DIY enthusiasts, providing not only a wide range of products but also expert advice and tips for various projects. Customers can connect with merchants to purchase items directly at competitive prices, enhancing their gardening and home improvement endeavors. ManoMano's data-driven approach enables efficient product offerings, making it a valuable resource for individuals looking to undertake DIY projects.

LumApps

Series C in 2020
LumApps is a developer of a social and collaborative intranet platform designed to enhance employee engagement and communication within organizations. Founded in 2012 and headquartered in Tassin, France, with additional offices in major cities such as San Francisco, New York, London, Paris, and Tokyo, LumApps provides a centralized hub for accessing corporate resources, personalized content, and social communities. The platform is fully integrated with major collaborative suites, including Google G Suite and Microsoft Office 365, allowing employees to access corporate news, work applications, and social interactions seamlessly. By breaking down communication silos, LumApps aims to foster healthier work relationships and improve collaboration among employees, thereby supporting companies in their digital transformation efforts.

Specify

Pre Seed Round in 2020
Specify is a design data platform founded in Paris in 2018 by a team of former designers, product managers, and developers. The company assists organizations in managing their brand identity by automatically collecting, storing, and distributing design tokens and assets. This capability enables clients to maintain brand consistency across various products and platforms. After successfully onboarding over 1,000 international teams and two years of bootstrapping, Specify secured a pre-seed investment of $1 million. The company has positioned itself as a leader in the DesignOps and Design Systems sectors, being the first to offer a dedicated Design Data Platform. Additionally, Specify is an active member of the Design Tokens Community Group, which aims to establish standards for sharing design elements across tools and products at scale.

TISSIUM

Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

ACINQ

Series A in 2019
Founded in 2014 and based in Paris, France, ACINQ is a startup focused on developing products and services for the Bitcoin ecosystem. The company specializes in blockchain technology that facilitates high throughput, instant payments, and low transaction fees. ACINQ's solutions aggregate incoming payments and enable periodic transaction dispatches to recipients' wallets. This approach allows clients to enjoy instant, low-cost payment options and receive funds as they would through traditional cash transactions, enhancing the efficiency and convenience of financial exchanges within the Bitcoin network.

Wifirst

Private Equity Round in 2019
Wifirst is a telecom operator based in Paris, France, that specializes in providing high-performance wireless internet and connectivity services for various enterprises across Europe and Africa. Founded in 2002, the company focuses on meeting the increasing demand for internet usage through its robust network infrastructure. Wifirst offers a diverse array of services, including wireless internet, fiber optic installations, managed LAN solutions, and firewall services, as well as internet protocol television and voice-over-internet protocol offerings. With a commitment to enhancing digital transformation, Wifirst operates hundreds of thousands of secure and intuitive connected spaces, ensuring that its clients remain connected in an evolving digital landscape.

Checkmyguest

Venture Round in 2019
Checkmyguest is a rental management company based in Paris, France, specializing in short-term rentals and mobility leases. Founded in 2016, the company focuses on transforming commercial premises into seasonal rental accommodations, allowing property owners to optimize profitability. Checkmyguest offers a comprehensive service that manages the entire rental process, from the initial study phase to full operation. In addition, the company provides a reservations tracking service and enhances the appeal of properties through professional photography, ensuring that accommodations attract future guests.

HostnFly

Series A in 2019
HostnFly is a rental management services company based in Paris, France, founded in 2016. The firm specializes in optimizing revenue for property owners renting out their apartments on platforms like Airbnb. HostnFly provides a comprehensive suite of services that includes creating advertisements, selecting guests, managing housekeeping, and maintaining properties. By utilizing algorithms designed to enhance income from rentals, the company guarantees stable rental income for owners, ensuring a seamless and convenient renting process.

Ornikar

Series B in 2019
Ornikar SAS is an online driving school based in Paris, France, established in 2014. The company specializes in providing an affordable and streamlined approach to obtaining a driving license, catering to the needs of current and future generations. Ornikar offers a platform where candidates can learn and practice traffic laws, supported by a network of state-qualified instructors who deliver mobile driving lessons at reduced prices. In addition to facilitating access to driving licenses, Ornikar also provides tailored options for first-time car buyers and young driver insurance, enhancing the overall learning experience and promoting automotive mobility.

Pili

Series A in 2019
PILI Inc. is a company based in Paris, France, that specializes in researching and manufacturing bio-fabricated colors derived from microorganisms. Founded in 2012, the company focuses on designing enzymes and fermentation biotechnologies that convert sugar into sustainable and long-lasting dyes and pigments. PILI produces renewable inks as an eco-friendly alternative to traditional toxic and non-recyclable options. The company emerged from a collaboration among a biologist, a designer, and a financial analyst in a biohacker space, leading to the creation of innovative products like a pen fed by bacteria. By utilizing microorganisms, PILI aims to replace petrochemical and non-sustainable vegetable dyes, promoting sustainable development while also helping businesses reduce costs.

ManoMano

Series D in 2019
ManoMano is an online marketplace specializing in DIY, home improvement, and gardening products. Founded in 2013 and headquartered in Paris, France, the platform serves a community of DIY enthusiasts, providing not only a wide range of products but also expert advice and tips for various projects. Customers can connect with merchants to purchase items directly at competitive prices, enhancing their gardening and home improvement endeavors. ManoMano's data-driven approach enables efficient product offerings, making it a valuable resource for individuals looking to undertake DIY projects.

Neurallys

Seed Round in 2019
Neurallys is a Paris-based company specializing in the development and production of medical devices for neurology and neurosurgery. The company has created an intelligent sensor that communicates with a smartphone to monitor intracranial pressure in patients with hydrocephalus. This innovative device aims to enhance patient comfort and provide neurosurgeons with a valuable tool for more effective management and follow-up of the condition, ultimately improving the quality of care for those affected by hydrocephalus.

Doctolib

Series E in 2019
Doctolib is an online healthcare booking platform and management software provider based in Paris, France, founded in 2013. The company offers a comprehensive service for healthcare practitioners, enabling them to manage appointments, reduce no-shows, and attract new patients. For patients, Doctolib provides a free and user-friendly online service that allows individuals to easily find local health practitioners and book appointments for medical or dental consultations at any time. By streamlining the appointment process, Doctolib enhances access to healthcare services for both professionals and patients, facilitating better management of consultations and patient interactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.